Evidence map›Paper›PMID 19841582›Full record

ReviewCurrent opinion in clinical nutrition and metabolic care2010

Regulation of nitric oxide production in health and disease.

Yvette C Luiking, Mariëlle P K J Engelen, Nicolaas E P Deutz

3 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Current opinion in clinical nutrition and metabolic care, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 133 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed, 3 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01774994 nacompletednot on this map

Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers

TypeinterventionalSponsorMaastricht University Medical CenterRan2004 to 2012Enrolled33ConditionsHealthyArmsstable isotope infusion for measurement of metabolism
NCT02352740 nacompletednot on this mapstarted 2013, after this paper: background citation

Characterization of the Metabolic Fate of an Oral L-arginine Form in Healthy Subjects Featuring Risk Factors Related to the Metabolic Syndrome.

TypeinterventionalSponsorInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'EnvironnementRan2013Enrolled32ConditionsOverweight, Hypertriglyceridemic WaistArmsA form Arginine, B form Arginine
NCT02354794 nacompletednot on this mapstarted 2014, after this paper: background citation

Effect of Oral Supplementation With One Form of L-arginine on Vascular Endothelial Function in Healthy Subjects Featuring Risk Factors Related to the Metabolic Syndrome.

TypeinterventionalSponsorInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'EnvironnementRan2014 to 2014Enrolled36ConditionsOverweight, Hypertriglyceridemic WaistArmsOne form of arginine, placebo
3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 3 syntheses or guidelines pooled it, 336 citations in OpenAlex.

  1. Pooled it
  2. The Effect ofNutrients · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. General View of Arachidonic Acid (AA) Metabolism.Reviews of physiology, biochemistry and pharmacology · 2027
    Review
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Adverse Outcome Pathways Applied to Space Radiation Research.Environmental and molecular mutagenesis · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Role of adenosine AEuropean journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yvette C LuikingCenter for Translational Research in Aging and Longevity, Donald W. Reynolds Institute on Aging, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Mariëlle P K J Engelen
Nicolaas E P Deutz
Institute on Aging · USUniversity of Arkansas for Medical Sciences · US

Funding

Optimal Amino Acid Nutrition in SepsisR01GM084447 · NIGMS · TEXAS A&M UNIVERSITY · PI DEUTZ, NICOLAAS E, WOLFE, ROBERT R · 2009 to 2012
$1.5M
NIGMS NIH HHS R01 GM084447
6 · The paper itself

Abstract

purpose of reviewThe purpose of this review is to highlight recent publications examining nitric oxide production in health and disease and its association with clinical nutrition and alterations in metabolism. RECENT

findingsThe role of the cofactor tetrahydrobiopterin in nitric oxide production and its relation with arginine availability is indicated as an important explanation for the arginine paradox. This offers potential for nitric oxide regulation by dietary factors such as arginine or its precursors and vitamin C. Because diets with a high saturated fat content induce high plasma fatty acid levels, endothelial nitric oxide production is often impaired due to a reduction in nitric oxide synthase 3 phosphorylation. Increasing the arginine availability by arginine therapy or arginase inhibition was, therefore, proposed as a potential therapy to treat hypertension. Recent studies in septic patients and transgenic mice models found that inadequate de-novo arginine production from citrulline reduces nitric oxide production. Citrulline supplementation may, therefore, be a novel therapeutic approach in conditions of arginine deficiency. SUMMARY: Both lack and excess of nitric oxide production in diseases can have various important implications in which dietary factors can play a modulating role. Future research is needed to expand our understanding of the regulation and adequate measurement of nitric oxide production at the organ level and by the different nitric oxide synthase isoforms, also in relation to clinical nutrition.

Indexed as

AnimalsArginaseArginineAscorbic AcidBiopterinsCitrullineDietDietary FatsEndotheliumHumansHypertensionMiceNitric OxideNitric Oxide Synthase Type IIISepsisArginaseArginineAscorbic AcidBiopterinsCitrullineDietary FatsNitric OxideNitric Oxide Synthase Type IIIsapropterin

Identifiers

PMID19841582
PMCPMC2953417
OpenAlexW2093580567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.